Given that gabapentin demonstrated an overall survival benefit, we next sought to understand its relationship to TSP-1 levels in resected tumor and patient serum; this was motivated by our prior work demonstrating that TSP-1 is a regulator of neuronal-driven tumor growth and is inhibited by gabapentin11. This evidence concerns the gene THBS1 and neoplasm.